Antibacterial phosphoinositides technical field
AssigneeAbbott Laboratories
InventorsShie-Ming Hwang, Yung-Sheng Huang, Jim-Wen Liu, Pradip Mukerji, Steven Neal Anderson, Jonathan A. Meulbroek
Life of this patent
Estimating the term…
Loading patent…
AssigneeAbbott Laboratories
InventorsShie-Ming Hwang, Yung-Sheng Huang, Jim-Wen Liu, Pradip Mukerji, Steven Neal Anderson, Jonathan A. Meulbroek
Estimating the term…
It has been discovered that certain phosphoinositides demonstrate antibacterial activity. Particularly, these phosphoinositides have been discovered to prevent the adhesion of H. influenzae onto the nasopharyngeal cells of mammals, and, in particular, humans. Phosphoinositides useful with the present invention have the following formula: 1 wherein R1 and R2 are selected from the group consisting of hydrogen and monounsaturated and saturated fatty acids having a carbon chain length of C6 to C20 and R1 and R2 can be the same or different; and R3 to R7 are selected from the group consisting of hydrogen or a phosphate moiety with at least two of R3 to R7 being a phosphate moiety; and hydrates and pharmaceutically acceptable salts thereof.
A nutritional formulation for the prophylaxis and treatment of Haemophilus influenzae infection and its clinical manifestations comprising an effective amount of a compound of the formula (1 4
A pharmaceutical composition for the prophylaxis and treatment of Haemophilus influenzae infection and its clinical manifestations comprising:
A method for the prophylaxis and treatment of bacterial infections comprising administering to a patient an effective amount of a compound of the formula (1):
A method for the prophylaxis and treatment of otitis media comprising administering to a patient an effective amount of a compound of the formula (1):
Dependencies are inferred from the claim text.